Intra-Cellular Therapies, Inc.
ITCIDelisted Apr 2, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567514
Intra-Cellular Therapies, Inc. was delisted on Apr 2, 2025; its insiders filed their last Form 4 on Apr 2, 2025; 395 institutions reported holding it in 13F filings for Q1 2025, worth $13.6B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in Intra-Cellular Therapies, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 274
- −7 vs. Q4 2022
- Shares held
- 83.9M
- +559.1K (+0.7%) vs. Q4 2022
- Total value
- $4.55B
- +$138.0M (+3.1%) vs. Q4 2022
- New holders
- 37
- 110 more added
- Sold out
- 44
- 86 more reduced
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ITCI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $2.54K |
| Q1 2026 | 1 | $2.54K |
| Q4 2025 | 1 | $2.54K |
| Q3 2025 | 1 | $2.54K |
| Q2 2025 | 4 | $4.15M |
| Q1 2025 | 395 | $13.6B |
| Q4 2024 | 387 | $8.08B |
| Q3 2024 | 356 | $7.12B |
| Q2 2024 | 376 | $6.62B |
| Q1 2024 | 346 | $6.15B |
| Q4 2023 | 335 | $6.42B |
| Q3 2023 | 294 | $4.54B |
| Q2 2023 | 288 | $5.34B |
| Q1 2023 | 274 | $4.55B |
| Q4 2022 | 283 | $4.41B |
| Q3 2022 | 274 | $3.89B |
| Q2 2022 | 266 | $4.65B |
| Q1 2022 | 241 | $4.94B |
| Q4 2021 | 208 | $3.60B |
| Q3 2021 | 181 | $2.56B |
| Q2 2021 | 187 | $2.74B |
| Q1 2021 | 170 | $2.30B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Intra-Cellular Therapies, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HSBC Holdings PLC | 0 | $0 | 0.00% | −3,954−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −2,687−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −891−100.0% | Sold out |
| Coppell Advisory Solutions Corp. | 0 | $0 | 0.00% | −891−100.0% | Sold out |
| Harvest Fund Management Co., Ltd | 0 | $0 | 0.00% | −581−100.0% | Sold out |
| Comerica Securities,inc. | 0 | $0 | 0.00% | −431−100.0% | Sold out |
| Macroview Investment Management LLC | 0 | $0 | 0.00% | −216−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −180−100.0% | Sold out |
| Beaird Harris Wealth Management, LLC | 0 | $0 | 0.00% | −88−100.0% | Sold out |
| Hall Laurie J Trustee | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Prestige Wealth Management Group LLC | 0 | $0 | 0.00% | −42−100.0% | Sold out |
| Centerpoint Advisors, LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Accurate Wealth Management, LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Horan Securities, Inc. | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Castleview Partners, LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −53−100.0% | Sold out |
| HealthInvest Partners AB | – | – | – | – | Not filed |
| Cornerstone Planning Group LLC | – | – | – | – | Not filed |